View Older Stories View More Recent Stories

Apr 8, 2016 04:30PM IsoRay, Inc. Announces Annual Meeting and Shareholder Record Dates
Mar 2, 2016 08:34AM IsoRay (ISR) Appoints Two New Marketing Execs
Mar 2, 2016 08:30AM IsoRay Appoints Michael L. Krachon as Vice President of Sales and Marketing and Lori A. Woods as Senior Marketing Consultant
Jan 14, 2016 08:03AM IsoRay (ISR) Names New CEO
Jan 14, 2016 08:00AM IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15
Jan 13, 2016 08:04AM IsoRay (ISR) Announces Publication of Peer-Reviewed Study on Cesuim-131 Cost Effectiveness
Jan 13, 2016 08:00AM Clinical Study Discusses Cost Effectiveness of Surgical Resection and IsoRay's Cesium-131 Intraoperative Brachytherapy
Jan 7, 2016 08:05AM IsoRay (ISR) CEO Dwight Babcock to Retire
Jan 7, 2016 08:00AM IsoRay Chairman and CEO Dwight Babcock to Retire
Dec 16, 2015 08:44AM IsoRay (ISR) Announces Publication of Cesium-131 Brachytherapy in Brain Metastases Study
Dec 16, 2015 08:30AM Weill Cornell Medical Clinical Study Demonstrates Cesium-131 Brachytherapy Seeds on a String Surgical Technique Promotes Dose Homogeneity and Minimizes the Risk of Radiation-Induced Injury
Dec 14, 2015 08:37AM IsoRay (ISR) Announced Recent Publication of Peer-Reviewed Results of Study Using Cesium-131 Brachytherapy
Dec 14, 2015 08:30AM Weill Cornell Clinical Study Notes Cesium-131 Brachytherapy Can Provide a Viable Alternative to Whole Brain Radiotherapy With Excellent Response Rates and Minimal Toxicity
Oct 14, 2015 08:15AM IsoRay's Proprietary Cesium-131 Product Line Will Be on Display at the American Society for Radiation Oncology (ASTRO) Convention
Aug 10, 2015 08:30AM Isoray, Inc. Announces Appointment of PCG Advisory Group as Investor, Public and Digital Communications Agency of Record
Jul 17, 2015 09:42PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Reminds Investors With Losses in IsoRay, Inc. of July 21, 2015 Deadline
Jul 16, 2015 08:30AM IsoRay's Cesium-131 Cancer Fighting Portfolio was on Display at the American Association of Physicists in Medicine (AAPM) Convention
Jul 3, 2015 08:19PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against IsoRay, Inc. And Advises Shareholders To Contact The Firm Prior To The Lead Plaintiff Deadline
Jun 29, 2015 08:30AM IsoRay's Cesium-131 Selected by Chicago Prostate Cancer Center for Use in the Launch of a Study of the Focal Treatment of Prostate Cancer
Jun 26, 2015 06:03PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against IsoRay, Inc. on Behalf of Investors
Jun 23, 2015 08:30AM IsoRay Intends to Vigorously Defend Litigation
Jun 22, 2015 08:30AM IsoRay Announces Appointment of New Director
Jun 17, 2015 08:30AM IsoRay's Quality Management System Granted Continued Certification to Highest ISO Standard for Medical Device Manufacturers
Jun 1, 2015 08:15AM IsoRay's Intra-Cranial Brachytherapy Brain Cancer Treatments Utilizing Cesium-131 Were Presented at the Brain Tumor Biotech Summit 2015
May 20, 2015 09:25AM IsoRay (ISR) Criticized for Overly Promotional Press Releases
May 20, 2015 08:15AM IsoRay's Cesium-131 Lung Cancer Treatment Reports 96% Success in Local Control and 100% Survival at 5 Years in High Risk Patients in Newly Published Report
May 18, 2015 08:30AM IsoRay, Inc. Reports Third Quarter Results
May 11, 2015 08:30AM IsoRay's Cesium-131 Cancer Treatment Takes Center Stage at Weill Cornell's International Symposium "Advances in Brachytherapy"
May 7, 2015 08:20AM Thomas Jefferson University Launches Major Head and Neck Cancer Study Utilizing Cesium-131 Where Current Standard of Care Treatments Have Failed
Apr 8, 2015 08:30AM IsoRay's Cancer Fighting Isotope Cesium-131 Will Be Featured in Four Oral Presentations at the American Brachytherapy Society (ABS) Convention in Orlando, Florida
Mar 24, 2015 08:00AM Gynecologic Cancers Successfully Treated Using IsoRay's Cesium-131 Will Be Presented by Dr. Jonathan Feddock Saturday Night While at the Society of Gynecologic Oncology Convention (SGO)
View More Recent Stories View Older Stories